Pfizer Pays $11.6 Billion for Drug-Maker in Its Biggest Deal Since 2016

Published on May 10, 2022

Pfizer announced it will buy migraine drug maker Biohaven for about $11.6 billion – in cash.

Continue reading on website
Other news

The age of the centaur: $100M ARR is the new cloud valuation milestone

May 10, 2022
Mary D'Onofrio Contributor Mary D'Onofrio is a partner and co-founder of the growth investment practice at Bessemer Venture Partners, where she primarily focuses on cloud software investments. More posts by this contributor Why we’re doubling down on cloud investments right now Adam Fisher Contributor Adam Fi

5 Web Design Tips You Can't Ignore in 2022

May 10, 2022
Great website design starts with the fundamentals. Here's how you can turn your website from boring and unhelpful to dynamic and valuable.